Premium
O‐018: Updated Follow‐up Analysis in the REP 401 Protocol: Treatment of HBeAg Negative Chronic HBV Infection with REP 2139 or REP 2165, Tenofovir Disoproxil Fumarate and Pegylated Interferon α‐2a
Publication year - 2018
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.15_12922
Subject(s) - tenofovir , pegylated interferon , chronic hepatitis , medicine , virology , hbeag , protocol (science) , interferon , human immunodeficiency virus (hiv) , hepatitis b virus , virus , ribavirin , alternative medicine , pathology , hbsag
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom